Motility abnormalities in gastroesophageal reflux disease

Area of Science:

• Gastroenterology
• Esophageal Motility Disorders

Background:

• Esophageal dysmotility is frequently observed in patients with gastroesophageal reflux disease (GERD).
• The underlying causes of these motility abnormalities, including the roles of acid exposure, inflammation, and fibrosis, are not fully understood.
• The potential for reversal of these dysmotilities with treatment is also uncertain.

Purpose of the Study:

• To investigate the relationship between GERD and esophageal dysmotility.
• To explore the impact of medical and surgical therapies on esophageal motility in GERD patients.
• To provide guidance on surgical approaches, particularly fundoplication, for patients with varying degrees of esophageal dysmotility.

Main Methods:

• The study reviews existing knowledge on GERD-associated esophageal dysmotility.
• It discusses the implications of preoperative dysmotility on postoperative outcomes, especially following fundoplication.
• It analyzes patient subsets who may experience improvement with therapy versus those at risk for surgical complications.

Main Results:

• Most GERD patients are unlikely to show significant improvement in esophageal motility with standard therapies.
• Fundoplication, especially complete wraps, can lead to severe dysphagia in patients with preoperative dysmotility.
• Patients with minimal motility abnormalities may safely undergo fundoplication, while those with severe abnormalities require caution.

Conclusions:

• A conservative approach, such as a partial fundoplication (Toupet), is recommended for patients with ineffective esophageal motility.
• Further research is needed to elucidate the pathogenesis of GERD-associated dysmotility and refine antireflux treatment strategies.
• Precise understanding of motility abnormalities can guide more effective antireflux therapy decisions.